Nutriband securs $2M line of credit financing facility

Nutriband has entered into a three-year $2,000,000 Credit Line facility to provide financing through the FDA approval process into commercial scale manufacturing for the Company’s patented lead product, AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal system. AVERSA Fentanyl contains Nutriband’s proprietary transdermal abuse deterrent technology.